0001811858-20-000001.txt : 20200519 0001811858-20-000001.hdr.sgml : 20200519 20200518175944 ACCESSION NUMBER: 0001811858-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200519 DATE AS OF CHANGE: 20200518 EFFECTIVENESS DATE: 20200519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Scorpion Therapeutics, Inc. CENTRAL INDEX KEY: 0001811858 IRS NUMBER: 845066858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367229 FILM NUMBER: 20890999 BUSINESS ADDRESS: STREET 1: 888 BOYLSTON STREET, SUITE 1111 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 734-355-6263 MAIL ADDRESS: STREET 1: 888 BOYLSTON STREET, SUITE 1111 CITY: BOSTON STATE: MA ZIP: 02199 D 1 primary_doc.xml X0708 D LIVE 0001811858 Scorpion Therapeutics, Inc. 888 BOYLSTON STREET, SUITE 1111 BOSTON MA MASSACHUSETTS 02199 212-841-1015 DELAWARE None None Corporation true 2020 Gary Glick 888 BOYLSTON STREET, SUITE 1111 BOSTON MA MASSACHUSETTS 02199 Executive Officer Director Peter Joseph Campisi, Jr. 888 BOYLSTON STREET, SUITE 1111 BOSTON MA MASSACHUSETTS 02199 Executive Officer Biotechnology Decline to Disclose 06b false 2020-04-23 false true false 0 Indefinite 24681250 Indefinite false 11 0 0 0 false Scorpion Therapeutics, Inc. /s/ Peter Joseph Campisi, Jr. Peter Joseph Campisi, Jr. Secretary and General Counsel 2020-05-18